Success Stories: In Just 12 Days, EB1-A Approval Won for a Chinese Instructor in Biomedical Engineering, Thanks to Premium Processing Upgrade and Our Team’s Work
Client’s Testimonial:
“Thanks a lot for all your assistance with my case!”
On May 6th, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for an Instructor in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Instructor
Country of Origin: China
State of Residence at the Time of Filing: Texas
Approval Notice Date: May 6th, 2022
Processing Time: 12 days (Premium Processing Requested)
Case Summary:
The EB1-A or Alien of Extraordinary Ability is a kind of employment-based immigrant visa for foreign nationals who have some extraordinary ability in the sciences, arts, education, business, or athletics which one can showcase through sustained national or international acclaim. Our team at NAILG specializes in EB1-A visas and has helped thousands of applicants get approval. So when a leading photoacoustic imaging expert in biomedical engineering from China came to NAILG for his EB1-A case, we made sure he got the best service and hence won the approval.
Our team ensured the success of his case by customizing his petition with the following information:
- He has achieved a consistent and notable record of success and influence in biomedical engineering and he is especially well-known for research on novel imaging contrasts for in vivo tumor imaging and bioluminescence tomography-guided systems.
- He is seen as an authority in the field and has been invited to review and evaluate the work of his peers no fewer than 11 times.
- In addition to directly advancing photoacoustic tomography, bioluminescence tomography-guided systems, and in vivo tumor imaging through his original research and peer review service, he has actively engaged his peers in the field of biomedical engineering by authoring and co-authoring 18 peer-reviewed articles and 1 book chapter that have been published in international journals.
- Additionally, his overall work has been cited a massive total of 1,215 times by peers in at least 57 countries using his prior findings to make additional discoveries.
- Due to its clear implications for the rapid and effective diagnosis of cancerous tumors, his breakthrough research has already attracted the attention of the private sector as well.
- Along with this, his work has received 4 letters of recognition from other experts who wrote to corroborate the worth and excellence of our client’s research in the area. Two of these letters have been quoted from below:
“Due to [the client’s] cutting-edge developments, scientists and physicians are able to find and diagnose tumors earlier and more accurately, and this is especially salient in the context of American public health. Therefore, it is imperative that [the client] continue his research in the United States. His novel methods improve the prognosis for millions of Americans by providing earlier and more accurate detection of cancerous tumors. In order for progress to continue at its current pace, [the client] must remain in the nation.”
Thus, the petition packet was packed with information about his work and its excellence, which aided in the quick adjudication of his case. Another factor that helped him get the approval in just 12 days was the premium processing upgrade. So, we are glad to have been of assistance to him in this process, and we wish him the best in his future endeavors.